<!DOCTYPE html>
<html lang="en">
<head>
<?php $id='1953-1222'; include '../../seo.php';?>
<?php include '../../side-nav.php';?>
<div class="page-content">
<!--section-->
<div class="section mt-0">
<div class="breadcrumbs-wrap">
<div class="container">
<div class="breadcrumbs">
<a href="https://sprintdiagnostics.in/">Home</a>
<a href="https://www.sprintdiagnostics.in/hyderabad/test/">Test</a>
<span>ALL Cytogenetics 2</span>
</div>
</div>
</div>
</div>
<!--//section-->
<!--section-->
<div class="section page-content-first">
<div class="container mt-6">
<div class="row">
<div class="col-md-8 col-lg-8 mt-0 mt-md-0 mb-4">
<h1 class="test-h1">ALL Cytogenetics 2 (Karyotyping + FISH for BCR-ABL1 + TEL- AML1 + MLL) </h1>
<div class="post-text">
<p>ALL Cytogenetics 2 is a highly specialized diagnostic panel, used for evaluating patients suspected to have Acute Lymphoblastic Leukemia (ALL), a cancer of the white blood cells. This panel includes karyotyping and Fluorescence In Situ Hybridization (FISH) tests, which are used to examine the chromosomes in a sample of blood or bone marrow. The main focus is on detecting chromosomal abnormalities that are often associated with ALL, specifically BCR-ABL1, TEL-AML1, and MLL rearrangements. These chromosomal changes can be essential in diagnosing ALL, understanding its progression, and making critical treatment decisions.</p>
<div class="table-wrap">
<table class="table table-striped">
	<thead>
		<tr>
			<th scope="col">Test Name</th>
			<td scope="col">ALL Cytogenetics 2 (Karyotyping + FISH for BCR-ABL1 + TEL- AML1 + MLL) </td>
		</tr>
	</thead>
	<tbody>
		<tr>
			<th scope="row">Sample Type</th>
			<td> Bone Marrow or Blood </td>
		</tr>
		<tr>
			<th scope="row">Preparations Required</th>
			<td>No specific preparations such as fasting are required. However, it is important to inform the doctor about any medications being taken. </td>
		</tr>
		<tr>
			<th scope="row">Report Time</th>
			<td>12 days </td>
		</tr>
		<tr>
			<th scope="row">Price in Hyderabad</th>
			<td>₹ 13250 </td>
		</tr>
	</tbody>
</table>
</div>
<div class="post-text">
	<h2 class="test-h2 mt-3">What is Acute Lymphoblastic Leukemia (ALL)? </h2>
	<p>ALL is a type of blood cancer where the bone marrow makes too many lymphocytes, a type of white blood cell. This overproduction of immature cells can hinder the bone marrow's ability to produce healthy blood cells. </p>
	<h2 class="test-h2 mt-3">Why is the ALL Cytogenetics 2 panel essential? </h2>
	<p>This panel is essential for the diagnosis and management of ALL. The detection of chromosomal abnormalities provides vital information on the type and severity of leukemia, which can guide treatment strategies. </p>
	<!--section achieved-->
	<?php include "../../include/iconsbox.php" ?>
	<!--//section achieved-->
	<h2 class="test-h2 mt-3">What information does the ALL Cytogenetics 2 panel provide? </h2>
	<p>The panel provides information on chromosomal structure and abnormalities, such as BCR-ABL1, TEL-AML1, and MLL rearrangements. This information is crucial for diagnosing ALL, determining the subtype, and deciding on the most effective treatment plan. </p>
	<h2 class="test-h2 mt-3">When should I get this test done? </h2>
	<p>This test is typically done when a patient shows signs and symptoms suggestive of ALL, such as fatigue, fever, and easy bruising, or when other blood tests indicate abnormal results. </p>
	<h2 class="test-h2 mt-3">Is there any specific preparation required for this test? </h2>
	<p> No specific preparation such as fasting is required for this test. However, it’s important to inform the doctor about any medications or supplements being taken, as they might interfere with the results</p>
	<h2 class="test-h2 mt-3"> What are normal values for this test?</h2>
	<p>Normal results would indicate that no abnormal chromosomal changes or rearrangements are present. However, the presence of certain abnormalities can indicate ALL or a specific subtype. </p>
	<h2 class="test-h2 mt-3"> What factors can affect the levels?</h2>
	<p>Factors such as the presence of leukemia cells, genetic mutations, and ongoing treatment can affect the results of this test. </p>
	<h2 class="test-h2 mt-3">Are there any risks associated with this test? </h2>
	<p>The risks are similar to those of a regular blood draw, including pain, bleeding, or infection at the puncture site. If a bone marrow sample is required, there might be additional risks. </p>
	<h2 class="test-h2 mt-3">How does this test affect treatment decisions? </h2>
	<p>The results of this panel can significantly influence treatment decisions. Identifying specific chromosomal abnormalities allows doctors to choose targeted therapies that are more likely to be effective against the particular subtype of ALL. </p>
	<h2 class="test-h2 mt-3">Which doctor should I consult if I have abnormal values? </h2>
	<p>If there are abnormal values, it’s crucial to consult a hematologist or oncologist who specializes in blood disorders and cancer. </p>
	<h2 class="test-h2 mt-3">How often should this test be done? </h2>
	<p>This test is generally done at the time of diagnosis and may be repeated if monitoring for specific genetic changes is necessary during treatment, or if there is a relapse. </p>
	<h2 class="test-h2 mt-3">What is the role of FISH in this panel? </h2>
	<p>FISH is used to detect specific genetic changes and chromosomal rearrangements that are too small to be seen with karyotyping. It helps in identifying specific subtypes of ALL, which can be critical for prognosis and treatment. </p>
	<h2 class="test-h2 mt-3">What is karyotyping? </h2>
	<p>Karyotyping is a test that evaluates the number and structure of chromosomes in cells. In ALL, karyotyping is used to find out if there are changes in the chromosomes of cells that might be causing or advancing the leukemia. </p>
	<h2 class="test-h2 mt-3">Can lifestyle or dietary changes impact the results or management of ALL? </h2>
	<p> While lifestyle and dietary changes may contribute to the overall health of a patient with ALL, they are unlikely to significantly impact the results of the genetic tests or the course of the disease. <br><br>
Understanding the genetic makeup of Acute Lymphoblastic Leukemia is critical for ensuring the best possible outcome. The ALL Cytogenetics 2 panel is a fundamental component of the diagnostic process and guides the decision-making for treatment strategies. It's important to keep in communication with the doctor and actively participate in the management and treatment plan.
</p>
	
</div>		
</div>			
</div>
<!--form section-->
<?php include "../../include/bookslot.php" ?>
<!--form section-->
</div>
</div>
<!--//section-->
</div>
</div>
<?php include '../../footer.php';?>
</body>
</html>